Emergent Biosolutions Stock Forward View - Simple Regression
| EBS Stock | USD 11.04 0.01 0.09% |
Emergent Stock outlook is based on your current time horizon.
At this time the rsi of Emergent Biosolutions' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Emergent Biosolutions hype-based prediction, you can estimate the value of Emergent Biosolutions from the perspective of Emergent Biosolutions response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Emergent Biosolutions on the next trading day is expected to be 12.25 with a mean absolute deviation of 0.72 and the sum of the absolute errors of 44.14. Emergent Biosolutions after-hype prediction price | USD 10.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Emergent Biosolutions to cross-verify your projections. Emergent Biosolutions Additional Predictive Modules
Most predictive techniques to examine Emergent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Emergent using various technical indicators. When you analyze Emergent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Emergent Biosolutions Simple Regression Price Forecast For the 11th of February 2026
Given 90 days horizon, the Simple Regression forecasted value of Emergent Biosolutions on the next trading day is expected to be 12.25 with a mean absolute deviation of 0.72, mean absolute percentage error of 0.74, and the sum of the absolute errors of 44.14.Please note that although there have been many attempts to predict Emergent Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Emergent Biosolutions' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Emergent Biosolutions Stock Forecast Pattern
| Backtest Emergent Biosolutions | Emergent Biosolutions Price Prediction | Research Analysis |
Emergent Biosolutions Forecasted Value
In the context of forecasting Emergent Biosolutions' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Emergent Biosolutions' downside and upside margins for the forecasting period are 8.40 and 16.11, respectively. We have considered Emergent Biosolutions' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Emergent Biosolutions stock data series using in forecasting. Note that when a statistical model is used to represent Emergent Biosolutions stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.8133 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.7235 |
| MAPE | Mean absolute percentage error | 0.0629 |
| SAE | Sum of the absolute errors | 44.135 |
Predictive Modules for Emergent Biosolutions
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Emergent Biosolutions. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Emergent Biosolutions After-Hype Price Density Analysis
As far as predicting the price of Emergent Biosolutions at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Emergent Biosolutions or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Emergent Biosolutions, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Emergent Biosolutions Estimiated After-Hype Price Volatility
In the context of predicting Emergent Biosolutions' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Emergent Biosolutions' historical news coverage. Emergent Biosolutions' after-hype downside and upside margins for the prediction period are 7.13 and 14.85, respectively. We have considered Emergent Biosolutions' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Emergent Biosolutions is somewhat reliable at this time. Analysis and calculation of next after-hype price of Emergent Biosolutions is based on 3 months time horizon.
Emergent Biosolutions Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Emergent Biosolutions is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Emergent Biosolutions backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Emergent Biosolutions, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 3.86 | 0.00 | 0.01 | 0 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.04 | 10.99 | 0.45 |
|
Emergent Biosolutions Hype Timeline
On the 10th of February Emergent Biosolutions is traded for 11.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Emergent is forecasted to decline in value after the next headline, with the price expected to drop to 10.99. The average volatility of media hype impact on the company price is insignificant. The price depreciation on the next news is expected to be -0.45%, whereas the daily expected return is currently at 0.11%. The volatility of related hype on Emergent Biosolutions is about 7720.0%, with the expected price after the next announcement by competition of 11.03. About 77.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.98. Some equities with similar Price to Book (P/B) outperform the market in the long run. Emergent Biosolutions has Price/Earnings To Growth (PEG) ratio of 1.55. The entity had not issued any dividends in recent years. Considering the 90-day investment horizon the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Emergent Biosolutions to cross-verify your projections.Emergent Biosolutions Related Hype Analysis
Having access to credible news sources related to Emergent Biosolutions' direct competition is more important than ever and may enhance your ability to predict Emergent Biosolutions' future price movements. Getting to know how Emergent Biosolutions' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Emergent Biosolutions may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SIGA | SIGA Technologies | 0.00 | 0 per month | 1.48 | 0.03 | 3.73 | (2.37) | 8.50 | |
| SNDL | SNDL Inc | 0.03 | 11 per month | 0.00 | (0.06) | 5.06 | (5.88) | 37.98 | |
| ESPR | Esperion Therapeutics | 0.00 | 0 per month | 3.73 | 0.04 | 6.53 | (7.02) | 24.91 | |
| AQST | Aquestive Therapeutics | (0.11) | 10 per month | 0.00 | (0.06) | 7.10 | (7.62) | 45.05 | |
| RIGL | Rigel Pharmaceuticals | 0.46 | 10 per month | 0.00 | (0.03) | 7.75 | (6.40) | 21.12 | |
| ORGO | Organogenesis Holdings | 0.00 | 0 per month | 0.00 | (0.23) | 5.75 | (7.07) | 19.91 | |
| PRTA | Prothena plc | (0.17) | 10 per month | 0.00 | (0.08) | 5.10 | (4.47) | 14.00 | |
| CMPS | Compass Pathways Plc | 0.46 | 7 per month | 3.72 | 0.05 | 8.25 | (5.59) | 21.95 | |
| CRVS | Corvus Pharmaceuticals | (0.46) | 8 per month | 3.10 | 0.12 | 9.63 | (7.20) | 174.42 | |
| OLMA | Olema Pharmaceuticals | (0.71) | 8 per month | 3.01 | 0.14 | 9.82 | (5.86) | 145.73 |
Other Forecasting Options for Emergent Biosolutions
For every potential investor in Emergent, whether a beginner or expert, Emergent Biosolutions' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Emergent Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Emergent. Basic forecasting techniques help filter out the noise by identifying Emergent Biosolutions' price trends.Emergent Biosolutions Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Emergent Biosolutions stock to make a market-neutral strategy. Peer analysis of Emergent Biosolutions could also be used in its relative valuation, which is a method of valuing Emergent Biosolutions by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Emergent Biosolutions Market Strength Events
Market strength indicators help investors to evaluate how Emergent Biosolutions stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Emergent Biosolutions shares will generate the highest return on investment. By undertsting and applying Emergent Biosolutions stock market strength indicators, traders can identify Emergent Biosolutions entry and exit signals to maximize returns.
| Accumulation Distribution | 22129.23 | |||
| Daily Balance Of Power | 0.0222 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 11.23 | |||
| Day Typical Price | 11.16 | |||
| Price Action Indicator | (0.18) | |||
| Period Momentum Indicator | 0.01 |
Emergent Biosolutions Risk Indicators
The analysis of Emergent Biosolutions' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Emergent Biosolutions' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting emergent stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.75 | |||
| Semi Deviation | 3.89 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.87 | |||
| Downside Variance | 16.41 | |||
| Semi Variance | 15.16 | |||
| Expected Short fall | (2.81) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Emergent Biosolutions
The number of cover stories for Emergent Biosolutions depends on current market conditions and Emergent Biosolutions' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Emergent Biosolutions is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Emergent Biosolutions' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Emergent Biosolutions Short Properties
Emergent Biosolutions' future price predictability will typically decrease when Emergent Biosolutions' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Emergent Biosolutions often depends not only on the future outlook of the potential Emergent Biosolutions' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emergent Biosolutions' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53 M | |
| Cash And Short Term Investments | 99.5 M |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.